Case of Yellow Fever Vaccine–Associated Viscerotropic Disease with Prolonged Viremia, Robust Adaptive Immune Responses, and Polymorphisms in CCR5 and RANTES Genes
Open Access
- 15 August 2008
- journal article
- case report
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 198 (4) , 500-507
Abstract
Background. The live attenuated yellow fever vaccine 17D (YF-17D) is one of the most effective vaccines. Despite its excellent safety record, some caKeywords
This publication has 31 references indexed in Scilit:
- Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever VaccinesImmunity, 2008
- Migratory fate and differentiation of blood monocyte subsetsImmunobiology, 2006
- Yellow fever vaccine-associated viscerotropic disease and death in SpainJournal of Clinical Virology, 2006
- Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunityJournal of Experimental Medicine, 2006
- Yellow fever vaccine: An updated assessment of advanced age as a risk factor for serious adverse eventsVaccine, 2005
- Analysis of Genetic Polymorphisms in CCR5, CCR2, Stromal Cell–Derived Factor–1, RANTES, and Dendritic Cell–Specific Intercellular Adhesion Molecule–3–Grabbing Nonintegrin in Seronegative Individuals Repeatedly Exposed to HIV‐1The Journal of Infectious Diseases, 2004
- Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX®Vaccine, 2004
- Active participation of CCR5+CD8+ T lymphocytes in the pathogenesis of liver injury in graft-versus-host diseaseJournal of Clinical Investigation, 1999
- Enzymatic Activity of 2′–5′-Oligoadenylate Synthetase Is Impaired by Specific Mutations that Affect Oligomerization of the ProteinJournal of Biological Chemistry, 1997
- Effects of Mutating Specific Residues Present Near the Amino Terminus of 2′–5′-Oligoadenylate SynthetaseJournal of Biological Chemistry, 1997